Preterm Birth Prevention and Management Market Size, Share, and Outlook, H2-2025 Report- By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Or
Description
Preterm Birth Prevention and Management Market Outlook
The global Preterm Birth Prevention and Management Market Size is valued at $1.9 Billion in 2025 and is forecast to reach $2.7 Billion in 2032 at a CAGR of 5.4%.
The Preterm Birth Prevention and Management Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Preterm Birth Prevention and Management Market segments across 22 countries from 2021 to 2032. Key segments covered include By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Preterm Birth Prevention and Management Market Insights, 2025
In 2025, the preterm birth prevention and management market is characterized by advanced diagnostics, pharmacologic interventions, and personalized care protocols aimed at reducing neonatal morbidity and mortality. Innovations include progesterone therapies, cervical length monitoring via ultrasound, and targeted lifestyle or behavioral interventions. Research is focusing on genetic and biomarker-driven risk assessment to enable early detection and intervention. Regulatory frameworks ensure maternal and fetal safety for both medications and devices. Adoption is growing in maternal-fetal medicine clinics, hospitals, and telehealth services for high-risk pregnancies. Integration of predictive analytics and remote monitoring devices improves patient adherence and clinical outcomes. Overall, the market reflects precision obstetrics, proactive risk management, and a focus on improving neonatal health.
Five Trends Shaping the Global Preterm Birth Prevention and Management Market in 2025 and Beyond
The global Preterm Birth Prevention and Management Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Preterm Birth Prevention and Management Industry?
The Preterm Birth Prevention and Management Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Preterm Birth Prevention and Management Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Preterm Birth Prevention and Management Market Segment Insights
The Preterm Birth Prevention and Management Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Preterm Birth Prevention and Management Industry Value Chain
The chapter identifies potential companies and their operations across the global Preterm Birth Prevention and Management Industry ecosystem. It assists decision-makers in evaluating global Preterm Birth Prevention and Management Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Preterm Birth Prevention and Management Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Preterm Birth Prevention and Management Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Preterm Birth Prevention and Management Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Preterm Birth Prevention and Management Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Preterm Birth Prevention and Management Market.
Europe Preterm Birth Prevention and Management Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Preterm Birth Prevention and Management Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Preterm Birth Prevention and Management Industry competitiveness. The report analyses the key Preterm Birth Prevention and Management Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Preterm Birth Prevention and Management Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Preterm Birth Prevention and Management Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Preterm Birth Prevention and Management Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Preterm Birth Prevention and Management Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Preterm Birth Prevention and Management Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Preterm Birth Prevention and Management Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AbbVie Inc, Bayer AG, Covis Pharma GmbH, Ferring Pharmaceuticals B.V., Merck & Co. Inc, ObsEva SA, Pfizer Inc, Takeda Pharmaceutical Company Ltd, Viatris Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Preterm Birth Prevention and Management Market Scope
Leading Segments
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Leading Companies
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Preterm Birth Prevention and Management Market Size is valued at $1.9 Billion in 2025 and is forecast to reach $2.7 Billion in 2032 at a CAGR of 5.4%.
The Preterm Birth Prevention and Management Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Preterm Birth Prevention and Management Market segments across 22 countries from 2021 to 2032. Key segments covered include By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Preterm Birth Prevention and Management Market Insights, 2025
In 2025, the preterm birth prevention and management market is characterized by advanced diagnostics, pharmacologic interventions, and personalized care protocols aimed at reducing neonatal morbidity and mortality. Innovations include progesterone therapies, cervical length monitoring via ultrasound, and targeted lifestyle or behavioral interventions. Research is focusing on genetic and biomarker-driven risk assessment to enable early detection and intervention. Regulatory frameworks ensure maternal and fetal safety for both medications and devices. Adoption is growing in maternal-fetal medicine clinics, hospitals, and telehealth services for high-risk pregnancies. Integration of predictive analytics and remote monitoring devices improves patient adherence and clinical outcomes. Overall, the market reflects precision obstetrics, proactive risk management, and a focus on improving neonatal health.
Five Trends Shaping the Global Preterm Birth Prevention and Management Market in 2025 and Beyond
The global Preterm Birth Prevention and Management Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Preterm Birth Prevention and Management Industry?
The Preterm Birth Prevention and Management Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Preterm Birth Prevention and Management Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Preterm Birth Prevention and Management Market Segment Insights
The Preterm Birth Prevention and Management Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, Others), By Route of Administration (Oral, Parenteral, Vaginal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Preterm Birth Prevention and Management Industry Value Chain
The chapter identifies potential companies and their operations across the global Preterm Birth Prevention and Management Industry ecosystem. It assists decision-makers in evaluating global Preterm Birth Prevention and Management Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Preterm Birth Prevention and Management Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Preterm Birth Prevention and Management Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Preterm Birth Prevention and Management Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Preterm Birth Prevention and Management Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Preterm Birth Prevention and Management Market.
Europe Preterm Birth Prevention and Management Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Preterm Birth Prevention and Management Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Preterm Birth Prevention and Management Industry competitiveness. The report analyses the key Preterm Birth Prevention and Management Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Preterm Birth Prevention and Management Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Preterm Birth Prevention and Management Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Preterm Birth Prevention and Management Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Preterm Birth Prevention and Management Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Preterm Birth Prevention and Management Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Preterm Birth Prevention and Management Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AbbVie Inc, Bayer AG, Covis Pharma GmbH, Ferring Pharmaceuticals B.V., Merck & Co. Inc, ObsEva SA, Pfizer Inc, Takeda Pharmaceutical Company Ltd, Viatris Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Preterm Birth Prevention and Management Market Scope
Leading Segments
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
Others
By Route of Administration
Oral
Parenteral
Vaginal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Leading Companies
AbbVie Inc
Bayer AG
Covis Pharma GmbH
Ferring Pharmaceuticals B.V.
Merck & Co. Inc
ObsEva SA
Pfizer Inc
Takeda Pharmaceutical Company Ltd
Viatris Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
196 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Preterm Birth Prevention and Management Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Preterm Birth Prevention and Management Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Preterm Birth Prevention and Management Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Preterm Birth Prevention and Management Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Preterm Birth Prevention and Management Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Therapy
- Progesterone Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Antibiotics Therapy
- Heparin Profylaxis Therapy
- Others
- By Route of Administration
- Oral
- Parenteral
- Vaginal
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- 6. Global Preterm Birth Prevention and Management Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Preterm Birth Prevention and Management Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Preterm Birth Prevention and Management Market Trends and Growth Opportunities
- 6.2.1 North America Preterm Birth Prevention and Management Market Outlook by Type
- 6.2.2 North America Preterm Birth Prevention and Management Market Outlook by Application
- 6.3 North America Preterm Birth Prevention and Management Market Outlook by Country
- 6.3.1 The US Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 6.3.2 Canada Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 6.3.3 Mexico Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7. Europe Preterm Birth Prevention and Management Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Preterm Birth Prevention and Management Market Trends and Growth Opportunities
- 7.2.1 Europe Preterm Birth Prevention and Management Market Outlook by Type
- 7.2.2 Europe Preterm Birth Prevention and Management Market Outlook by Application
- 7.3 Europe Preterm Birth Prevention and Management Market Outlook by Country
- 7.3.2 Germany Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.3 France Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.4 The UK Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.5 Spain Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.6 Italy Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.7 Russia Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Preterm Birth Prevention and Management Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Preterm Birth Prevention and Management Market Outlook by Type
- 8.2.2 Asia Pacific Preterm Birth Prevention and Management Market Outlook by Application
- 8.3 Asia Pacific Preterm Birth Prevention and Management Market Outlook by Country
- 8.3.1 China Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.2 India Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.3 Japan Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.4 South Korea Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.5 Australia Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.6 South East Asia Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 9. South America Preterm Birth Prevention and Management Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Preterm Birth Prevention and Management Market Trends and Growth Opportunities
- 9.2.1 South America Preterm Birth Prevention and Management Market Outlook by Type
- 9.2.2 South America Preterm Birth Prevention and Management Market Outlook by Application
- 9.3 South America Preterm Birth Prevention and Management Market Outlook by Country
- 9.3.1 Brazil Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 9.3.2 Argentina Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Preterm Birth Prevention and Management Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Preterm Birth Prevention and Management Market Outlook by Type
- 10.2.2 Middle East and Africa Preterm Birth Prevention and Management Market Outlook by Application
- 10.3 Middle East and Africa Preterm Birth Prevention and Management Market Outlook by Country
- 10.3.1 Saudi Arabia Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10.3.2 The UAE Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10.3.4 South Africa Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10.3.5 Egypt Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Preterm Birth Prevention and Management Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- AbbVie Inc
- Bayer AG
- Covis Pharma GmbH
- Ferring Pharmaceuticals B.V.
- Merck & Co. Inc
- ObsEva SA
- Pfizer Inc
- Takeda Pharmaceutical Company Ltd
- Viatris Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
